Sheila Gujrathi, Chief Medical Officer at Receptos, holds 0.00 shares in Receptos (Ticker: RCPT), holds 0.00 shares in Five Prime Therapeutics (Ticker: FPRX), holds 115.14K shares in Janux Therapeutics Inc (Ticker: JANX).
Sheila Gujrathi latest transaction was an Uninformative Sell of ―.
What was Sheila Gujrathi's most profitable transaction?
Sheila Gujrathi’s most profitable transaction was an Informative Sell of VTYX stock on March 31, 2023. The return on the trade was 83.50%.
What is Sheila Gujrathi's role in Receptos?
Sheila Gujrathi's role in Receptos is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.